Skip to main content

Advertisement

Log in

Demographic and clinical characteristics of patients with ANCA-positive vasculitis in a Colombian University Hospital over a 12-year period: 2005–2017

  • Observational Research
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Vasculitides associated with anti-neutrophil cytoplasmic antibodies are heterogeneous, systemic, low prevalence and high morbidity and mortality entities. They include granulomatosis with polyangiitis, microscopic polyangiitis and eosinophilic granulomatosis with polyangiitis. In Latin America, there are few descriptive registries of these patients. The objective of the study was to describe the demographic and clinical characteristics and in-hospital morbidity and mortality of patients with vasculitis associated with anti-neutrophil cytoplasmic antibodies in a university hospital in Colombia. This was a cross-sectional descriptive study. We performed computer searches with terms related to patients with anti-neutrophil cytoplasmic antibody-associated vasculitis, between 2005 and 2017 who met the American College of Rheumatology classification criteria for vasculitis associated with anti-neutrophil cytoplasmic antibodies, and their clinical and laboratory characteristics. One hundred and six patients with anti-neutrophil cytoplasmic antibody-associated vasculitis were included in the study. The average age was 55 years, and 57.5% were women. In 68.8% of the cases, the diagnosis was made during hospitalization, with an average hospital stay of 16.6 days (± 12.22). The distribution by type of vasculitis was: granulomatosis with polyangiitis 52%, microscopic polyangiitis 45.2% and eosinophilic granulomatosis with polyangiitis 1.8%. Alveolar hemorrhage occurred in 35% of patients; 20.7% had variable renal involvement, of which 53.8% progressed to advanced kidney disease. Treatment included glucocorticoids 91.5%, cyclophosphamide 62.2%, plasmapheresis 14.1%, and 41.5% required renal replacement therapy. In-hospital mortality was 16.5%, Sepsis was the most common cause of death. We present clinical information on a group of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis; renal involvement was the the most common type of affectation. Both the clinical and serological characteristics of our registry were similar to those described in other Latin American and European cohorts, and a lower in-hospital mortality rate was evidenced.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ochoa CD, Ramírez F, Quintana G, Toro C, Cañas C, Osio LF et al (2009) Epidemiology of primary vasculitis in Colombia and its relation with reported for latin america. Rev Colomb Reumatol 16(3):248–263

    Google Scholar 

  2. Pomares Quimbaya A, Gonzalez RA, Muñoz O, García OM, Bohorquez WR (2017) A strategy for prioritizing electronic medical records using structured analysis and natural language processing. Ing y Univ [Internet] 22(1):7–31. https://revistas.javeriana.edu.co/index.php/iyu/article/view/17809

  3. Azaola AH, Alvarez CAN (2016) Anti-neutrophil cytoplasmic antibody-associated vasculitis in Mexican population: clinical phenotype, autoantibody profile and renal characteristics. J Vasc [Internet] 2(2) https://www.omicsonline.org/open-access/antineutrophil-cytoplasmic-antibody-associated-vasculitis-in-mexicanpopulation-clinical-phenotype-autoantibody-profile-and-renal-ch-2471-9544-100110.php?aid=75935

  4. Solans-Laqué R, Fraile G, Rodriguez-Carballeira M, Caminal L, Castillo MJ, Martínez-Valle F, et al. (2017) Clinical characteristics and outcome of Spanish patients with ANCA-associated vasculitides: impact of the vasculitis type, ANCA specificity, and treatment on mortality and morbidity. Medicine (Baltimore) [Internet] 96(8):e6083. https://www.ncbi.nlm.nih.gov/pubmed/28225490

  5. Wójcik K, Wawrzycka-Adamczyk K, Włudarczyk A, Sznajd J, Zdrojewski Z, Masiak A, et al. (2019) Clinical characteristics of Polish patients with ANCA-associated vasculitides—retrospective analysis of POLVAS registry. Clin Rheumatol [Internet] https://link.springer.com/10.1007/s10067-019-04538-w

  6. Sada K, Yamamura M, Harigai M, Fujii T, Dobashi H, Takasaki Y, et al. (2014) Classification and characteristics of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study. Arthritis Res Ther [Internet] 16(2):R101. https://www.ncbi.nlm.nih.gov/pubmed/24758294

  7. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. (2013) 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum [Internet] 65(1):1–11. https://www.ncbi.nlm.nih.gov/pubmed/23045170

  8. Yumura W, Kobayashi S, Suka M, Hayashi T, Ito S, Nagafuchi H, et al. (2014) Assessment of the Birmingham vasculitis activity score in patients with MPO-ANCA-associated vasculitis: sub-analysis from a study by the Japanese Study Group for MPO-ANCA-associated vasculitis. Mod Rheumatol [Internet] 24(2):304–9. https://www.ncbi.nlm.nih.gov/pubmed/24593206

  9. Guillevin L, Pagnoux C, Seror R, Mahr A, Mouthon L, Le Toumelin P, et al. (2011) The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine (Baltimore) [Internet] 90(1):19–27. https://www.ncbi.nlm.nih.gov/pubmed/21200183

  10. (2018) Epidemiology is a science of high importance. Nat Commun [Internet] 9(1):1703. https://www.nature.com/articles/s41467-018-04243-3

  11. Scott DGI, Watts RA (2013) Epidemiology and clinical features of systemic vasculitis. Clin Exp Nephrol [Internet] 17(5):607–10. https://www.ncbi.nlm.nih.gov/pubmed/23843034

  12. Yamagata K, Usui J, Saito C, Yamaguchi N, Hirayama K, Mase K, et al. (2012) ANCA-associated systemic vasculitis in Japan: clinical features and prognostic changes. Clin Exp Nephrol [Internet] 16(4):580–8. https://www.ncbi.nlm.nih.gov/pubmed/22350463

  13. Lionaki S, Blyth ER, Hogan SL, Hu Y, Senior BA, Jennette CE, et al. (2012) Classification of antineutrophil cytoplasmic autoantibody vasculitides: The role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis. Arthritis Rheum [Internet] 64(10):3452–62. https://doi.wiley.com/10.1002/art.34562

  14. Tan JA, Dehghan N, Chen W, Xie H, Esdaile JM, Avina-Zubieta JA (2017) Mortality in ANCA-associated vasculitis: ameta-analysis of observational studies. Ann Rheum Dis [Internet] 76(9):1566–74. https://www.ncbi.nlm.nih.gov/pubmed/28468793

  15. Chaudhry R, Bilal A, Austin A, Mehta S, Salman L, Foulke L, et al. (2007) EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: Focus on anti-neutrophil cytoplasm antibody-associated vasculitis. J Bras Nefrol [Internet] 66(5):605–17. https://www.ncbi.nlm.nih.gov/pubmed/30095143

  16. Poulton CJ, Nachman PH, Hu Y, McGregor JG, Jennette JC, Falk RJ, et al. (2013) Pathways to renal biopsy and diagnosis among patients with ANCA small-vessel vasculitis. Clin Exp Rheumatol [Internet] 31(1 Suppl 75):S32–7. https://www.ncbi.nlm.nih.gov/pubmed/23343774

  17. Pagnoux C (2016) Updates in ANCA-associated vasculitis. Eur J Rheumatol [Internet] 3(3):122–33. https://www.eurjrheumatol.org/sayilar/207/buyuk/122-133.pdf

  18. Jennette JC, Nachman PH (2017) ANCA Glomerulonephritis and Vasculitis. Clin J Am Soc Nephrol [Internet] 12(10):1680–91. https://cjasn.asnjournals.org/lookup/doi/10.2215/CJN.02500317

  19. Lepeytre F, Royal V, Lavoie P-L, Bollée G, Gougeon F, Beauchemin S, et al. (2019) Estimating the change in renal function during the first year of therapy in ANCA-associated vasculitis. Kidney Int Rep [Internet] 4(4):594–602. https://www.ncbi.nlm.nih.gov/pubmed/30993234

  20. Walsh M, Merkel PA, Peh CA, Szpirt W, Guillevin L, Pusey CD, et al. (2013) Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trial. Trials [Internet] 14(1):73. https://trialsjournal.biomedcentral.com/articles/10.1186/1745-6215-14-73

  21. Dadonienė J, Kumžaitė G, Mačiulytė R, Miltinienė D (2017) Clinical characteristics and long-term survival differences of the ANCA-associated vasculitis group: a cross-sectional study of 27 patients. Acta Medica Litu [Internet] 24(2):107–12. https://www.ncbi.nlm.nih.gov/pubmed/28845128

  22. Salmela A, Törnroth T, Poussa T, Ekstrand A (2018) Clinical Study Prognostic Factors for Survival and Relapse in ANCA-Associated Vasculitis with Renal Involvement: A Clinical Long-Term Follow-Up Study. Int J Nephrol [Internet]. https://doi.org/10.1155/2018/6369814

  23. Chaudhry R, Bilal A, Austin A, Mehta S, Salman L, Foulke L, et al. (2018) ANCA associated vasculitis: experience of a tertiary care referral center. Brazilian J Nephrol [Internet]. https://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002018005024102&lng=en&tlng=en

  24. Wu C-S, Hsieh C-J, Peng Y-S, Chang T-H, Wu Z-Y (2015) Antineutrophil cytoplasmic antibody-associated vasculitis in Taiwan: a hospital-based study with reference to the population-based National Health Insurance database. J Microbiol Immunol Infect [Internet] 48(5):477–82. https://www.ncbi.nlm.nih.gov/pubmed/24560699

Download references

Acknowledgements

The authors scknowledge the San Ignacio University Hospital and the Pontificia Universidad Javeriana

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Julián Rondón-Carvajal.

Ethics declarations

Conflict of interest

None of the authors declare that they have conflict of interest in relation to this manuscript

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Daniel G. Fernández-Ávila is the first author.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fernández-Ávila, D.G., Rondón-Carvajal, J., Villota-Eraso, C. et al. Demographic and clinical characteristics of patients with ANCA-positive vasculitis in a Colombian University Hospital over a 12-year period: 2005–2017. Rheumatol Int 40, 1283–1290 (2020). https://doi.org/10.1007/s00296-020-04631-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-020-04631-3

Keywords

Navigation